Notice Regarding Determination of Selling Price, etc.
Filed with TSE · · 3 pages · English
Summary by 6ix AI
CKD Corporation has announced the determination of the selling price for a secondary offering of its shares, as resolved by the Board of Directors. The selling price is set per share, with details on the total amount and underwriting price also provided. The delivery date for the shares is scheduled for a specified day in late October. This document serves as a press release regarding the secondary offering and clarifies that it is not intended for soliciting investments in the United States.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from CKD
- Notice Regarding Secondary Offering of Shares
- Notice Regarding Determination of Matters Concerning Repurchase of Shares
- Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP) (Completion of Interim Review by an Independent Auditor)
- Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
- Notice Regarding Completion of the Disposal of Treasury Stock as Restricted Stock Compensation to Directors
Follow CKD into a list and get an email when it puts out news.
Follow CKD